Zheng M - Search Results

1

Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL.

Chen L, Ren A, Zhao Y, Chen H, Wu Q, Zheng M, Zhang Z, Zhang T, Zhong W, Lin J, Zhu H. Chen L, et al. Among authors: zheng m. J Hematol Oncol. 2023 Nov 22;16(1):113. doi: 10.1186/s13045-023-01513-6. J Hematol Oncol. 2023. PMID: 37993905 Free PMC article.

2

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H. Wu C, et al. Among authors: zheng m. Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27. Acta Pharm Sin B. 2020. PMID: 32292689 Free PMC article.

3

Metal-Protein Nanoparticles Facilitate Anti-VSV and H1N1 Viruses Through the Coordinative Actions on Innate Immune Responses and METTL14.

Zhu XJ, Feng JQ, Zheng MZ, Yang ZR, Zhao L, Zhang W, Zhong W, Chen YY, Lin J. Zhu XJ, et al. Macromol Biosci. 2021 Apr;21(4):e2000382. doi: 10.1002/mabi.202000382. Epub 2021 Feb 1. Macromol Biosci. 2021. PMID: 33522144

4

5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.

Chu JL, Bi SH, He Y, Ma RY, Wan XY, Wang ZH, Zhang L, Zheng MZ, Yang ZQ, Du LW, Maimaiti Y, Biekedawulaiti G, Duolikun M, Chen HY, Chen L, Li LL, Tie L, Lin J. Chu JL, et al. Among authors: zheng mz. Front Endocrinol (Lausanne). 2022 Jul 29;13:910907. doi: 10.3389/fendo.2022.910907. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35966076 Free PMC article.

5

Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase.

Yang KY, Wu CR, Zheng MZ, Tang RT, Li XZ, Chen LX, Li H. Yang KY, et al. Bioorg Chem. 2019 Nov;92:103186. doi: 10.1016/j.bioorg.2019.103186. Epub 2019 Aug 12. Bioorg Chem. 2019. PMID: 31465967

6

3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Li M, Wu C, Yang Y, Zheng M, Yu S, Wang J, Chen L, Li H. Li M, et al. Among authors: zheng m. Cell Oncol (Dordr). 2021 Jun;44(3):541-556. doi: 10.1007/s13402-021-00599-9. Epub 2021 Mar 18. Cell Oncol (Dordr). 2021. PMID: 33735398 Review.

7

Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.

Yang Y, Zheng M, Han F, Shang L, Li M, Gu X, Li H, Chen L. Yang Y, et al. Among authors: zheng m. J Mol Med (Berl). 2022 Apr;100(4):599-612. doi: 10.1007/s00109-022-02181-8. Epub 2022 Feb 25. J Mol Med (Berl). 2022. PMID: 35212782

8

Clinical characteristics and predictive factors of subclinical diabetic nephropathy.

Zhang Y, Yang J, Zheng M, Wang Y, Ren H, Xu Y, Yang Y, Cheng J, Han F, Yang X, Chen L, Shan C, Chang B. Zhang Y, et al. Among authors: zheng m. Exp Clin Endocrinol Diabetes. 2015 Feb;123(2):132-8. doi: 10.1055/s-0034-1396810. Epub 2015 Jan 21. Exp Clin Endocrinol Diabetes. 2015. PMID: 25607340

9

Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.

Zheng M, Wu C, Yang K, Yang Y, Liu Y, Gao S, Wang Q, Li C, Chen L, Li H. Zheng M, et al. Pharmacol Res. 2021 Feb;164:105367. doi: 10.1016/j.phrs.2020.105367. Epub 2020 Dec 8. Pharmacol Res. 2021. PMID: 33307221

10

Structure based discovery of novel hexokinase 2 inhibitors.

Liu Y, Li M, Zhang Y, Wu C, Yang K, Gao S, Zheng M, Li X, Li H, Chen L. Liu Y, et al. Among authors: zheng m. Bioorg Chem. 2020 Mar;96:103609. doi: 10.1016/j.bioorg.2020.103609. Epub 2020 Jan 21. Bioorg Chem. 2020. PMID: 32007722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,504 results

Search Page

Filters